Dyadic International Inc (DYAI) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Dyadic International Inc   (NASDAQ: DYAI)


Dyadic International Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Dyadic International Inc's ROI in the second quarter of 2026?
Dyadic International Inc recorded a cumulative net loss of $-8 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -144.09%.

Within the Healthcare sector 657 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 4003 to 4111.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -20.52 % -25.45 % -31.22 % -24.51 % -19.01 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 3 5 6 8 4
Return On Investment (TTM) -144.09 % -126.92 % -121.29 % -115.21 % -83.78 %
DYAI's Overall Ranking # 4111 # 4003 # 3596 # 3584 # 3581
Seq. Investment Change TTM -7.93 % -5.38 % -4.8 % -4.16 % -13.64 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -8 -7 -7 -7 -6




Return On Investment DYAI's Ranking
Within: No.
Industry # 112
Sector # 658
Overall # 4111

Return On Investment Statistics
High Average Low
25412.23 %
2304.54 %
-144.09 %
(Sep 30 2023)   (Jun 30 2026)



  News about Dyadic International Inc Return on Investment ROI

Dyadic International Announces Changes in Board and Achieves Record-breaking ROI in Q3 2023

March 28, 2024



Dyadic International, a leading biotechnology company specializing in large-scale protein manufacturing, recently made significant changes to its board and management leadership roles. The announcement included the stepping down of Chairman Michael Tarnok, the appointment of Patrick Lucy as the new Chairman, the retirement of Dr. Barry Buckland, and the appointment of Joseph Hazelton as the Chief Operating Officer. Concurrently, Dyadic International achieved an impressive return on average invested assets (ROI) in its third quarter of 2023, setting a new company record.
New Board Appointments:
Effective immediately, Michael Tarnok, Chairman of Dyadic International s board of directors, has decided to step down from his position. Patrick Lucy, a current board member, has been appointed to succeed Tarnok as the new Chairman. Mr. Tarnok will continue to serve as a director until June 2025 when he expects to retire. Additionally, Dr. Barry Buckland announced his retirement and will not stand for re-election at the Company s annual meeting in June 2024. As a result, the Board s size will reduce from seven to six members.






Financial Statements
Dyadic International Inc's II. Quarter Investments $ 3 Millions DYAI's Balance sheet
Dyadic International Inc's II. Quarter Income $ -2 Millions Quarterly DYAI's Income Statement
DYAI's Income by Division See DYAI's Income by Division


DYAI Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 6 7 6 11 19
Y / Y Investment Growth -16.36 % 25.39 % -47.02 % -39.9 % -34.11 %
Net Income in Millions -7 -6 -7 -10 -26
Y / Y Net Income Growth - - - - -
Annual Return On Investment -117.68 % -77.64 % -113.88 % -86.43 % -139.46 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DYAI's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DYAI's Competitors
Subscribers only: Roi for Dyadic International Inc's Suppliers
Subscribers only: Return On Investment for DYAI's Customers

Other Ratios
DYAI's Roa DYAI's Inventory Turnover Ratio DYAI's Growth Rates DYAI's Dividend Statistics
DYAI's Profitability Ratios DYAI's Asset Turnover Ratio DYAI's Dividend Growth
DYAI's Roe DYAI's Valuation Ratios DYAI's Financial Strength Ratios DYAI's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-26T07:36:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.